Joint Statement I Prevention at the heart of Europe’s Beating Cancer Plan
Europe’s Beating Cancer Plan needs a thorough prevention pillar to tackle challenges common to all non-communicable diseases (NCDs), reads a statement by 30+ health organisations. NCDs, such as cardiovascular disease, cancer, respiratory…
Experts discuss latest research and future of liver cancer
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the…
EASL Postgraduate course now available in Chinese, Japanese, Portuguese and Spanish
Every year, the EASL Postgraduate course highlights many clinical practice dilemmas and engages the audience with world-renowned experts on how to make the best management decisions to help patients with liver disease.…
EASL expresses deep sadness at the sudden passing of Prof. Fritz von Weizsäcker
EASL expresses deep sadness at the sudden passing of Prof. Fritz von Weizsäcker, who died on 19 November 2019 at the age of 59. Prof. von Weizsäcker was an expert for gastroenterology,…
Discover EASL Campus – your open-access eLearning hub for hepatology and liver-related disease
We’re pleased to announce the launch of our improved multi-disciplinary eLearning hub, EASL Campus, designed to help you develop your hepatology and liver-related disease knowledge through a variety of open-access, high quality…
Prof. Jordi Bruix receives AASLD 2019 achievement award
EASL member and former secretary-general (2002-2003) Professor Jordi Bruix was honoured with the Distinguished Achievement Award at The Liver Meeting® 2019, held this week by the American Association for the Study of…
Global hepatology societies call for better HCV testing and access to treatment
Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment. BOSTON, 8 November 2019. The societies, in partnership with the Clinton…